These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35295953)

  • 1.
    Deng M; Xiong C; He ZK; Bin Q; Song JZ; Li W; Qin J
    Front Genet; 2022; 13():825901. PubMed ID: 35295953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
    Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
    Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells.
    Tian C; Zeng S; Luo J
    Onco Targets Ther; 2020; 13():5353-5361. PubMed ID: 32606753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer.
    Luo Z; Wang Y; Bi X; Ismtula D; Wang H; Guo C
    Transl Cancer Res; 2023 Jul; 12(7):1765-1786. PubMed ID: 37588751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
    Zhong Y; Zhuang Z; Mo P; Shang Q; Lin M; Gong J; Huang J; Mo H; Huang M
    Evid Based Complement Alternat Med; 2021; 2021():5557873. PubMed ID: 34567213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.
    Zhang W; Xiao Y; Zhou Q; Zhu X; Zhang Y; Xiang Q; Wu S; Song X; Zhao J; Yuan R; Xiao B; Li L
    Biochem Genet; 2024 Oct; 62(5):3709-3739. PubMed ID: 38198023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
    Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
    PeerJ; 2021; 9():e12506. PubMed ID: 34993016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma.
    Zhang B; Han D; Yang L; He Y; Yang S; Wang H; Zhang X; Du Y; Xiong W; Ha H; Shang P
    BMC Cancer; 2023 Oct; 23(1):986. PubMed ID: 37845657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PICALM as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltration in Breast Cancer.
    A N; Lyu P; Yu Y; Liu M; Cheng S; Chen M; Liu Y; Cao X
    Appl Biochem Biotechnol; 2024 Sep; 196(9):6011-6027. PubMed ID: 38175412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
    Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
    Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer - A Comprehensive Bioinformatics Analysis.
    Chen S; Jin Z; Xin L; Lv L; Zhang X; Gong Y; Liu J
    Int J Gen Med; 2021; 14():9733-9745. PubMed ID: 34934348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
    Zhang P; Xie X; Li C; Zhang C; Liang P
    Cancer Med; 2023 Oct; 12(19):19758-19776. PubMed ID: 37706625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.